Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT05766046Not ApplicableActive Not Recruiting

Lung Cancer Prevention Screening Programme in Italy

Role: collaborator

NCT05509075Unknown

Nutraceuticals and Functional Foods

Role: collaborator

NCT04322513Unknown

Biomarkers for Identification of COVID-19 Infection

Role: collaborator

NCT04832542Completed

Implantable Loop Recorder in Traumatic Syncope

Role: collaborator

NCT04322344Phase 2Unknown

Escin in Patients With Covid-19 Infection

Role: collaborator

NCT03793998Unknown

Catheter Ablation of Arrhythmias With High Density Mapping System in the Real World Practice.

Role: lead

NCT02591875Unknown

Atrial Flutter Ablation in a Real World Population

Role: lead

All 7 trials loaded